STIMULATED [S-35] GTP-GAMMA-S BINDING BY 5-HT1A RECEPTOR AGONISTS IN RECOMBINANT CELL-LINES - MODULATION OF APPARENT EFFICACY BY G-PROTEIN ACTIVATION STATE

Citation
Pj. Pauwels et al., STIMULATED [S-35] GTP-GAMMA-S BINDING BY 5-HT1A RECEPTOR AGONISTS IN RECOMBINANT CELL-LINES - MODULATION OF APPARENT EFFICACY BY G-PROTEIN ACTIVATION STATE, Naunyn-Schmiedeberg's archives of pharmacology, 356(5), 1997, pp. 551-561
Citations number
49
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00281298
Volume
356
Issue
5
Year of publication
1997
Pages
551 - 561
Database
ISI
SICI code
0028-1298(1997)356:5<551:S[GBB5>2.0.ZU;2-#
Abstract
G-protein activation by different 5-HT receptor ligands was investigat ed in h5-HT1A receptor-transfected C6-glial and HeLa cells using agoni st-stimulated [S-35]GTP gamma S binding to membranes in the presence o f excess GDP.5-HT (10 mu M) stimulated [S-35]GTP gamma S binding in th e C6-glial membrane preparation to a larger extent than in the HeLa pr eparation; maximal responses with 30 mu M GDP were 490 +/- 99 and 68 /- 12%, respectively. With the 5-HT receptor agonists that were being investigated, the two preparations displayed the same rank order of po tency for stimulation of [S-35]GTP gamma S binding. In the C6-glial pr eparation at 0.3 mu M GDP, the rank order of maximal effects was: 5-HT (1.00) > 8-OH-DPAT (0.90) = R(+)-8-OH-DPAT (0.87)= 5-CT (0.86) = L694 247 (0.84) > S(-)8-OH-DPAT (0.68) = buspirone (0.67) = spiroxatrine (0 .67) = flesinoxan (0.64) > ipsapirone (0.53) = (-)pindolol (0.50) > SD Z216525 (0.25). However, differences in maximal response in the C6-gli al preparation were magnified by increasing the GDP concentrations, in dicating that the activity state of G-proteins can affect the maximal response. With the exception of 5-CT and L694247, increasing the amoun t of GDP to 30 mu M and higher concentrations resulted in an attenuati on of both the ligand's maximal effect (24 to 56%) and apparent potenc y (6 to 24-fold). Each of the [S-35]GTP gamma S binding responses was mediated by a 5-HT1A receptor as indicated by the competitive blockade by WAY100635 and spiperone. Only 5-CT and L694247 in some conditions displayed an efficacy similar to that of 5-HT at the h5-HT1A receptor; the other agents with intrinsic activity are partial agonists at this receptor. The data also suggest that the activity state of the G-prot eins is involved in the maximal effects that can be produced by activa ting the hS-HT1A receptor.